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mAbs recognizing TCR V gene products have helped to define a unique group
ofpotent T cell activators termed superantigens (1). Recognized superantigens in-
clude murine selfantigens (2, 3) and a group ofmicrobial toxins, the staphylococcal
enterotoxins(SE) (1), and a soluble product ofMycoplasma arthritidismitogen (MAM)
(4). Superantigens share a number ofintriguing characteristics. For example, su-
perantigen recognition is almost entirely a function ofTCR Va gene usage (1, 2).
In addition, superantigens bind selectively and with high affinity to MHC class II
molecules (6). In the absence ofantigen processing and in an MHC-nonrestricted
manner, superantigen-MHC classII complexeson the APC surfacetriggertheprolifer-
ationofTcellsexpressingthe relevantTCR V gene product (5). Finally, themicrobial
toxins that function as superantigens are among the most potent mitogens known.
The dual affinity of superantigens for MHC class II and TCR V gene products
suggests that this class ofantigen could promote a form ofabnormal Th-B cell col-
laboration analogous to that observed during graft-vs.-host disease (GVHD). In
GVHD, adoptive transfer ofdonor Th cells, specific for recipient MHC class II an-
tigens, triggers polyclonal B cell activation. In selected strains of nonautoimmune
prone mice, GVHD is characterized by an autoimmune diathesis remarkablysimilar
to SLE (6). It has been suggested that in GVHD, the presence ofboth selfantigens
and donor-derived Th cells, reactive against recipient MHC class II antigens, pro-
vides a combination ofstimuli that selectively drives autoreactive B cell differentia-
tion (6).
The experiments described below were designed to determine ifa superantigen
bridge between Th cells and B cells would result in an analogous form ofpolyclonal
human B cellactivation. MAMwas selected for study in view ofthe chronic inflam-
matory arthritis that M. arthritidis induces in rodents (7), and scattered reports of
M. arthritidis cultured from the bone marrow of patients with SLE (8).
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Materials and Methods
Reagents.
￿
PHA (Gibco Laboratories, Grand Island, NY) and PWM (Gibco Laborato-
ries) were used at a finalconcentration of 1 and 10 pg/ml, respectively. Staphylococcal entero-
toxin B (SEB) (Toxin Technology, Madison, WI) was used at 0.1 FAg/ml. Partially purified
MAM (isolated from M. arthritidis culture supernatants as described [4]) was used at a final
concentration of 1 :4,000, predetermined to be optimal for T cell proliferation.
Generation of Tcell lines (7UL).
￿
To optimize conditions for detecting B cell activation, MAM-
reactive CD4' TCL were analyzed rather than unselected resting T cell populations. PBL,
obtained from normal donors, were cultured at 2 x 106/cc in final medium supplemented
with a 1 :4,000 dilution of partially purified MAM, or 10 Rg/ml of the antiTCR V/35 mAb,
C37 (9). After 3 d, cultures were supplemented with partially purified human IL-2 (Electro-
Nucleonics Inc., Fairfield, NJ) and, 16-24 h later, blast and resting cells separated by cen-
trifugation on discontinuous Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden) gradients.
TCL were maintained in IL-2 and expanded by weekly retriggering with MAM or mAb
C37 plus X-irradiated autologous nonT cells (APC,«). Purified CD4' TCL were derived by
immune rosette depletion of CD8' T cells.
B Cell Helper Assay.
￿
B cell-enriched populations were isolated from fresh PBL or tonsils.
Briefly, T cells were removed by rosette formation with neuraminidase-treated sheep erythro-
cytes, followed by complement-mediated lysisof contaminating T cells by the mAb OKT3.
Resting B cells were isolated from monocytes and activated cells by density centrifugation
on discontinuous Percoll gradients. Responder B cells (5 x 105) were cultured in round-
bottomed culture tubes in 0.5 cc of final medium alone or with fresh autologous T cells (5 x
105), autologous CD4' MAM reactive, or mAb C37' TCL cells (105). Where indicated, cul-
tures were supplemented with PWM or MAM. TCL populations were X-irradiated (xr) with
500 rad to prevent overgrowth, a procedure that does not affect helper activity. After 10 d,
cultures were terminated and supernatants assayed for total IgM by ELISA.
Results and Discussion
After 4 d of in vitro sensitization with the partially purified superantigen, MAM-
responsive T cell blasts were isolated from the nonresponsive, resting T cell popula-
tion by discontinuous Percoll gradient centrifugation. Table I demonstrates that the
T cell blast population was enriched, and the resting T cell population depleted,
of MAM-reactive T cells, as determined by proliferation. The T cell blasts respond
to MAM with a vigorous and accelerated (day 2) proliferative response compared
with fresh PBL. In contrast, the resting T cell population proliferates to control stimuli,
either PHA or a distinct bacterial superantigen, SEB, but not to MAM.
Phenotypic analysis of the MAM blast population revealed approximately equal
distribution of CD4 + and CD8' T cells. To maximize the likelihood of detecting
MAM-dependent Th cell activity, the CD4' helper/inducer subset of MAM-
reactive T cell blasts was isolated by immune rosette depletion of CD8' cells. This
procedure yielded a T cell population that was >98% CD4', and maintained an
accelerated proliferative response to MAM in the presence ofautologous, allogeneic,
or xenogeneic APC (Table I, Exp. 3).
MAM-reactive CD4' T cell blasts were assayed for helper activity. As shown (Fig.
1 A), little IgM is produced in B cell cultures supplemented with MAM alone or
MAM plus unselected autologous T cells. In contrast, a striking IgM response is
induced in cultures containing both MAM-reactive CD4' T cell blasts and MAM .
This B cell response is MAM dependent, but not MHC restricted. Thus, B cells
derived from all donors tested, regardless of HLA haplotype, are activated by CD4'
MAM-reactive T cells in the presence of MAM (data not shown).TUMANG ET AL.
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TABLE I
Isolation of MAM-reactive T Cells by Percoll Density Gradient Centrifugation
PBL were cultured with MAM for 96 h, then separated into "blasts" and "resting" T cell populations by cen-
trifugation on discontinuous Percoll gradients. The separated populations were cultured for several days in
final medium supplemented with IL-2, washed extensively, and 2 x 104 cells assayed in triplicate for prolifer-
ation ([3H]TdR incorporation) triggered by 105 X-irradiated autologous non-T cells (APCxr) alone or in com-
bination with a 1?4,000 dilution ofMAM, lttg/ml of PHA (Exp. 1), or 0.1 Wg/ml of SEB (Exp. 2). In Exp.
1, freshly isolated autologous PBL was also assayed for proliferation. In Exps. 1 and 2, [3H]TdR incorpora-
tion was assayed on days 2, 4, and 6 ofculture. In Exp. 3, an aliquot ofthe MAM-reactive TCL, described
in Exp. 1, was depleted of CD8+ cells and assayed for proliferation against X-irradiated APC : either au-
tologous (AUTO-), allogeneic (ALLOxr), or xenogeneic rat splenocytes (Xenoxr) alone or in the presence
of MAM. [3H]TdR incorporation was assessed 36 h later.
In preliminary studies, we noted that MAM-reactive TCL, comprised of both
CD4' and CD8+ cells, often triggerlittle Ig production. This suggested restriction
of helper activity to the CD4' MAM-reactive T cell subset. The experiment
presented in Fig. 1 B confirms this impression. While both CD4' and CD8+ MAM-
reactive T cell blasts proliferate in response to MAM, only CD4} cells provide
MAM-dependent help for B cell activation, as assessed by Ig production.
In related studies, we examined TCR V-0 gene family usage by MAM-reactive
human T cells.'We noted a strong negative correlation between MAM-reactive T
cells and T cells expressing TCRV-0 5 gene products recognized by mAb C37 (9),
and Va 6.7 recognized bymAb OT145 (10). To prove that MAM-dependentB cell
activation requires superantigen-specific Th cells, CD4' TCL were obtained from
culturesofPBL stimulated with either MAMorthemAbC37. As expected, MAM-
reactive TCL were depleted ofC37-expressing cells, while the C37-stimulated cul-
ture contained >95To C37+ T cells. In functional assays (Fig. 2 A), the CD4+, C37+
TCLprovides help forB celldifferentiation inthe presence ofPWM. However, only
the MAM-reactive CD4` TCL drives B cell differentiation in the presence ofMAM.
Antibody production by resting B cells requires direct cognate cell-cell interac-
tion with antigen-specific Thcells, as well as the action oflymphokines (11). Recent
studies of GVHD in chimeric mice have demonstrated that autoantibody produc-
3H[TdR] incorporation
Exp.
Responder
cell
population APCxr
Day 2
MAM +
APCxr
PHA +
APCxr APCxr
Day 4
MAM +
APCxr
PHA +
APCxr APCxr
Day 6
MAM +
APCxr
PHA +
APCxr
CPM
1 T blasts 445 13,366 7,717 187 5,210 1,944 274 731 1,142
T resting ND 220 151 11,340 ND
PBL 140 378 8,115 397 1,186 38,410 743 4,844 1,572
SEB + SEB + SEB +
APCxr APCxr APCxr
2 T blasts 128 2,207 ND 141 3,314 ND 650 220 ND
T resting 189 299 1,359 124 274 2,946 483 328 1,066
MAM + MAM + MAM +
Medium MAM Auto., Auto., Alloxr Alloxr Xenoxr Xenoxr
3 CD4' MAM
blasts 180 727 931 19,504 386 14,370 434 5,5422156
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FIGURE 1 . MAM-dependent
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scribed above. Cytofluorograph-
is analysis of the unselected
MAM-reactive TCL blasts was
46% CD4', 520 /c CD8', the
CD8-depleted fraction was
>98% CD4', <1% CD8', and
the CD4-depleted fractions was
195% CD8', <1% CD4' . The
CD4' and CD8' fractionswere
assessed for B cell help as de-
scribed above. [3H]TdRincor-
poration by the CD4' and
CD8' populations to MAM in
the presence of autologous
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tioninthismodel is also dependent on cognate Th-B cellinteraction (12). Topostu-
late aroleforsuperantigens inthein vivo activation ofnormallyquiescent, autoreactive
B cells, it is crucial to demonstrate that superantigens can promote a productive
Th-resting B cellinteraction. To address this question, high density resting tonsillar
B cells were incubated with MAM or medium alone for 1 h at 37°C, then washed
extensively. These Bcell populationswere subsequently cultured with MAM-specific
Th cells and polyclonal IgM secretion assayed by ELISA. As shown in Fig. 2 B,
MAM-pulsed restingB cellsare excellent activators ofandtargets for MAM-reactive
CD4+ Tcellhelp in the absence ofexogenous MAM. These datademonstrate that
a mycoplasmal superantigen, bound to the surface of resting human B cells, is an
effectivemeans ofactivating superantigen-reactive Thcells that, in turn, triggerpoly-
clonal Ig production by the superantigen-bearing B cell population.
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FIGURE 2. Resting B cells
bind and present MAM to
specific Th cells. (A) CD4'
MAM-reactive or C37' TCL
were generated as described
above. Aliquots of these TCL
were assayed for polyclonal B
cell help as described in Fig. 1.
At the time ofassay, the MAM-
reactive line was >98% CD4'
and <0.1 C37' ; and the C37'
- ￿line was >98% CD4' and
1
￿
2
￿
3
￿
4
￿
5
￿
>96% C37' . The C37' T cell
ngrml I9M (xla'+)
￿
line did not proliferate or secrete
lymphokines in response to au-
tologous APCxr and MAM,
but proliferated vigorously and
secreted >100 jug/ml of IL-4 in
response to autologous APCxr
andmAbC37 (datanot shown).
(B) Restingtonsillar B cellswere
preincubated at 37°C with final
medium alone (B) or with a
1 :4,000 dilution of MAM
(BMAM). After 1 h, the B cells
were washedextensively before
use as responder cells in the
polyclonal IgM production
assay.
The observation that superantigens activate subsets of T cells based on TCR V
gene usage has led to speculation that these substances may induce organ-specific
autoimmunity by activating normally quiescent autoreactive Tcells(1). In addition,
however, the affinity ofsuperantigensfor MHC class II molecules and their recogni-
tion by Tcells in the absence of processing suggested to us that bacterial superan-
tigens may also perturb the immune system in a manner analogous to that seen
in GVHD. For example, any B cell, regardless of its specificity for antigen, may
bind asuperantigen andbe rendered atarget ofcognate Tcell helpby superantigen-
specific Thcells. Thestudies reported here support thishypothesis. While thismanu-
script was in preparation, Mourad et al. reported similar results using the
Staphylococcal toxic shock syndrome toxin (13). Together, these two reports suggest
thatproductive Th-B cell bridging may be acommon feature ofmicrobial superan-
tigens.
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Summary
Experimentally induced murine graft-vs.-host disease may be characterized by
hypergammaglobulinemia, autoantibody formation, and immune complex-mediated
organ system damage that mimics SLE. These autoimmune phenomena are medi-
ated by abnormal Th-B cell cooperation, across MHC disparities, in which donor-
derived allospecific Th cells recognize and interact with MHC class II antigens on
the surface ofrecipient B cells. Microbial toxins, termed superantigens, which bind
to MHC classII moleculesand activate selected Tcells based onTCRvariable gene
usage, may induce a similar form of Th-B cell interaction. In the present study,
we generated and characterized human Th cell lines reactive with the Mycoplasma
arthritidis superantigen (MAM). The essential observation is that resting human B
cells bind MAM and present it to superantigen-reactive autologous or allogeneic
Th cells, resultingin both Th cellactivation and aconsequent polyclonal Igresponse
by the superantigen-bearing B cells.
Receivedfor publication 29January 1990 and in revisedform 1 March 1990.
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